Shariati M, Evans KW, Zheng X, Bristow CA, et al. Combined inhibition of DDR1 and CDK4/6 induces synergistic effects in ER-positive, HER2-negative breast cancer with PIK3CA/AKT1 mutations. Oncogene 2021 Jun 9. pii: 10.1038/s41388-021-01819.
PMID: 34108622